U.S. Food and Drug Administration Approves Opdivo® + Yervoy® as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma Biotech Investing
Algernon Announces 75% Enrollment in Multinational Phase 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 Biotech Investing
AbbVie to Present New Data From 15 Abstracts at the 2020 Virtual Migraine Trust International Symposium Biotech Investing
Merck Announces Retirement of Dr. Roger M. Perlmutter; Dr. Dean Y. Li Appointed as President, Merck Research Laboratories Pharmaceutical Investing
UNCF, Bristol Myers Squibb Announce Second Cohort of the Ernest E. Just Postgraduate Fellowship and Extension of Partnership Through 2026 Biotech Investing
 Bristol Myers Squibb to Host Virtual Investor Event to Discuss Results from Phase 3 True North Trial Evaluating Zeposia® in Ulcerative Colitis at UEG Week 2020 Biotech Investing
Gilead Sciences Update on Supply and Distribution of Veklury® in the United States Biotech Investing
Nielsen's BASES Names LUMIFY® Eye Drops To 2020 U.S. BASES Top 25 Breakthrough Innovations List Medical Device Investing
Merck to Present New Data from the Company's Diverse HIV Portfolio and Pipeline at HIV Glasgow 2020 Pharmaceutical Investing
Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy Pharmaceutical Investing
